OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B
Emmanuel Deau, Mattias F. Lindberg, Frédéric Miege, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10694-10714
Closed Access | Times Cited: 14
Emmanuel Deau, Mattias F. Lindberg, Frédéric Miege, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10694-10714
Closed Access | Times Cited: 14
Showing 14 citing articles:
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome
Eva Lana‐Elola, Rifdat Aoidi, Miriam Llorian, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 18
Eva Lana‐Elola, Rifdat Aoidi, Miriam Llorian, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 18
DYRK1A kinase triplication is the major cause of Otitis Media in Down Syndrome
Hilda Tateossian, Amy Southern, Pratik Vikhe, et al.
(2025)
Open Access | Times Cited: 1
Hilda Tateossian, Amy Southern, Pratik Vikhe, et al.
(2025)
Open Access | Times Cited: 1
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer’s Disease
Huanhua Chen, Xudong Gao, Xinzhu Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12571-12600
Closed Access | Times Cited: 7
Huanhua Chen, Xudong Gao, Xinzhu Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12571-12600
Closed Access | Times Cited: 7
DYRK1A kinase triplication is the major cause of Otitis Media in Down Syndrome
Hilda Tateossian, Amy Southern, Pratik Vikhe, et al.
(2025)
Open Access
Hilda Tateossian, Amy Southern, Pratik Vikhe, et al.
(2025)
Open Access
Promotion of beta cell proliferation through DYRK kinase inhibition using the marine natural product breitfussin C
Sara Ullsten, Kine Ø. Hansen, Guillaume A. Petit, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sara Ullsten, Kine Ø. Hansen, Guillaume A. Petit, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A safe haven for cancer cells: tumor plus stroma control by DYRK1B
Miriam Ems, Anna Brichkina, Matthias Lauth
Oncogene (2025)
Open Access
Miriam Ems, Anna Brichkina, Matthias Lauth
Oncogene (2025)
Open Access
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate
Mattias F. Lindberg, Emmanuel Deau, Frédéric Miege, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15648-15670
Open Access | Times Cited: 10
Mattias F. Lindberg, Emmanuel Deau, Frédéric Miege, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15648-15670
Open Access | Times Cited: 10
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 2
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 2
Interneuron migration defects during corticogenesis contribute toDyrk1ahaploinsufficiency syndrome pathogenesis via actomyosin dynamics deregulations
María-Victoria Hinckelmann, Aline Dubos, Victorine Artot, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
María-Victoria Hinckelmann, Aline Dubos, Victorine Artot, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Originally Designed Dyrk1a Inhibitors as Potent Dyrk1a/Clk1/Clk4/Haspin Multiple Inhibitors: Synthesis and Biological Activities of Sulfur-Containing Tetracycles
Abdelfattah Faouzi, Alexandre Arnaud, François Hallé, et al.
(2024)
Closed Access
Abdelfattah Faouzi, Alexandre Arnaud, François Hallé, et al.
(2024)
Closed Access
Design, synthesis, and structure–activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors
Abdelfattah Faouzi, Alexandre Arnaud, François Hallé, et al.
RSC Medicinal Chemistry (2024)
Open Access
Abdelfattah Faouzi, Alexandre Arnaud, François Hallé, et al.
RSC Medicinal Chemistry (2024)
Open Access
Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor
Chao-Hsiang Peng, Tsong‐Long Hwang, Shao-Chi Hung, et al.
International Journal of Biological Macromolecules (2024), pp. 136860-136860
Open Access
Chao-Hsiang Peng, Tsong‐Long Hwang, Shao-Chi Hung, et al.
International Journal of Biological Macromolecules (2024), pp. 136860-136860
Open Access
Water-Mediated Synthesis of (E)-3-(1-Methyl-1H-benzo[d]imidazol-5-yl)-N-phenethylacrylamide, a Caffeic Acid Phenethyl Amide Analogue
Muppidi Subbarao, Sean M. Kerwin
Molbank (2024) Vol. 2024, Iss. 4, pp. M1915-M1915
Open Access
Muppidi Subbarao, Sean M. Kerwin
Molbank (2024) Vol. 2024, Iss. 4, pp. M1915-M1915
Open Access
Congenital heart defects in Down syndrome are caused by increased dosage of DYRK1A
Eva Lana‐Elola, Rifdat Aoidi, Miriam Llorian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Eva Lana‐Elola, Rifdat Aoidi, Miriam Llorian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
